RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > CDRH Compliance Director Silverman Leaving FDA

CDRH Compliance Director Silverman Leaving FDA

Posted 14 January 2015 | By Alexander Gaffney, RAC

CDRH Compliance Director Silverman Leaving FDA

The longtime director of the Center for Devices and Radiological Health's (CDRH) Office of Compliance, Steve Silverman, plans to leave the US Food and Drug Administration (FDA) next week to pursue other opportunities, press officials have confirmed to Regulatory Focus.

Silverman has been a central figure in CDRH's "Case for Quality," an effort to improve compliance among medical device manufacturers by focusing on common quality errors across the device industry. "We are consistently seeing a high volume of the same issues year after year," he noted in a 2013 presentation on the subject.

Silverman will be succeeded on an interim basis by Jan Welch, who now serves as the deputy director for Regulatory Affairs in CDRH's Office of Compliance. A search for a permanent successor to Silverman is now underway, FDA press official Jenny Haliski told Focus.


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.